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Abstract 
 
Complex I (NADH:ubiquinone oxidoreductase) uses the reducing potential of NADH to drive 
protons across the energy-transducing inner membrane and power oxidative phosphorylation 
in mammalian mitochondria. Recently, cryoEM analyses have produced close-to-complete 
models of all 45 subunits in the bovine, ovine and porcine complexes, and identifed two states 
relevant to complex I in ischemia-reperfusion injury. Here, we describe the 3.3-Å structure of 
complex I from mouse heart mitochondria, a biomedically-relevant model system, in the 
‘active’ state. We reveal a nucleotide bound in subunit NDUFA10, a nucleoside-kinase 
homolog, and define mechanistically-critical elements in the mammalian enzyme. By 
comparisons with a 3.9-Å structure of the ‘deactive’ state and with known bacterial structures 
we identify differences in helical geometry in the membrane domain that occur upon activation, 
or that alter the positions of catalytically-important charged residues. Our results demonstrate 
the capability of cryoEM analyses to challenge and develop mechanistic models for 
mammalian complex I. 
 
Introduction 
 
Respiratory complex I (NADH:ubiquinone oxidoreductase), one of the largest membrane-
bound enzymes in the cell, is a major entry point to the electron transport chain in mammalian 
mitochondria1. It powers ATP synthesis by capturing the free energy released by electron 
transfer from NADH to ubiquinone to drive protons across the inner membrane and support 
the proton-motive force. As an essential metabolic enzyme and an important contributor to 
cellular reactive oxygen species production, mutations in its subunits and assembly factors 
cause a wide range of inherited neuromuscular and metabolic diseases2. Mammalian complex 
I contains 45 subunits, encoded on both the nuclear and mitochondrial genomes1. Fourteen 
‘core’ subunits, conserved from bacteria to humans, are sufficient for catalysis, while 31 
‘supernumerary’ subunits are required for assembly, stability or regulation, or fulfil 
independent roles in mitochondrial metabolism3,4. 
 
Structural knowledge on mammalian complex I (Figure 1) has exploded recently. First, based 
on data from bacterial complex I5-7, the core subunits were modeled using a 5 Å single-particle 
electron cryomicroscopy (cryoEM) density map of the enzyme from Bos taurus (bovine) heart 
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mitochondria8. The architecture of the supernumerary ensemble was revealed around the core, 
and fourteen supernumerary subunits assigned. Crystallographic data on a membrane-domain 
subcomplex was then used for eight further assignments9. Subsequently, an improved-
resolution (4.2 Å) cryoEM map enabled modelling of all 45 subunits, providing the first 
structure of the entire mammalian complex10. Further structures of complex I from ovine-heart 
mitochondria11, and of the complex in the respirasome (a supercomplex of complexes I, III and 
IV) from porcine-heart mitochondria12 and cultured human cells13 have since improved the 
resolution to 3.6 Å, enabling more accurate models containing greater proportions of the 
residues and side chains. 
 
In complex I, NADH is oxidized by a flavin mononucleotide in the hydrophilic domain, then 
electrons are transferred along a chain of seven iron-sulfur (FeS) clusters to ubiquinone (Figure 
1), bound in a long channel at the interface between the hydrophilic and membrane domains. 
As first described in bacterial complex I6,7, then recapitulated for the yeast14 and mammalian 
complexes8,10,11, the membrane domain contains four antiporter-like units. They contain 
elements indicative of ion-transport activities, including p-bulges15,16, interrupted 
transmembrane helices (TMHs), and a series of buried charged residues linking them to the 
quinone-binding region. Computational simulations have suggested models for how the redox 
energy is captured, transferred and used to drive proton transfer17-20 but experimental support 
is lacking so the mechanisms remain undetermined. Solving structures of complex I trapped in 
different functional states provides a clear strategy to elucidate its mechanisms of catalysis, but 
focus on obtaining a complete model for the mammalian complex, rather than on understanding 
the mechanism, have so far left this opportunity little explored. 
 
Three distinct classes of particles were identified during the reconstruction of bovine complex 
I10. One (class 3) lacked key regions of density and was assigned to enzyme in the first stages 
of dissociation, whereas classes 2 and 1, which are related by subtle domain movements10, were 
tentatively assigned to the ‘active’ and ‘deactive’ states, respectively, both of which were 
present in the imaged preparation. The assignment was subsequently confirmed by imaging 
enzyme prepared in the deactive state21. The dominant class of ovine complex I11 corresponds 
to class 3 (partially dissociated), whereas the porcine12 and human13 respirasome complexes 
resemble the class 2 (active) state21. In the absence of substrates, mammalian complex I relaxes 
from the ‘active’ state, which is resting but ready to catalyze, into a profound resting state 
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called the ‘deactive’ state22-25. The ubiquinone-binding site in the deactive enzyme is partially 
disordered10,21, so the slow reactivation process that returns the enzyme to the active state upon 
addition of NADH and ubiquinone may be initiated by the site reforming around the 
ubiquinone substrate as it binds and is reduced21. Notably, lack of O2 prevents respiratory chain 
turnover so the deactive state forms spontaneously during ischemia26, and its slow reactivation 
has been proposed to protect against ischemia-reperfusion injury by minimizing reactive 
oxygen species production27. 
 
Here, we present a 3.3 Å resolution structure of complex I from mouse heart mitochondria in 
the active state (Figure 1). The improved resolution has revealed a nucleotide in the active site 
of the nucleoside-kinase homolog subunit NDUFA10, and provided structural definition of 
mechanistically-relevant elements in the mammalian enzyme. Furthermore, comparison with 
a 3.9 Å resolution structure of the mouse deactive state has uncovered conformational changes 
in the p-bulge in TMH3 of subunit ND6 that result in residues rotating around the helical axis 
upon activation. Similarly, comparison with bacterial structures has uncovered conformational 
changes in the p-bulges in TMH8 of ND2, ND4 and ND5 that alter the positions of charged 
residues required for proton translocation. Thus, our structures of mammalian complex I in 
defined states have revealed conformational variations in the membrane domain that may be 
necessary for catalysis to occur during the catalytic cycle, demonstrating their resolution is now 
sufficient to challenge and develop mechanistic models. 
 
Results 
 
Structure of mouse complex I 
 
A protocol for isolating pure, monodisperse and catalytically-active complex I from mouse-
heart mitochondria was miniaturized from that used to prepare complex I from bovine-heart 
mitochondria for previous cryoEM analyses8,10,21. The enzyme was frozen onto PEGylated gold 
grids21,28,29 and imaged using a Titan Krios microscope with a K2 detector at a calibrated pixel 
size of 1.05 Å. The final cryoEM density map reached a global resolution of 3.3 Å 
(Supplementary Figure 1 and Table 1), starting from 61K particles. In comparison, the bovine 
and ovine datasets contained 139K and 241K particles, respectively, for 4.2 and 3.9 Å 
resolution10,11. Furthermore, the final reconstruction contained only 20K particles in a single 
 5 
major class containing 70% of the 29K particles considered for 3D classification 
(Supplementary Figure 2), suggesting the mouse preparation is more homogenous than the 
bovine10 and ovine11 preparations, which each contained three major classes. The 3.3 Å 
resolution map contains many well-resolved features and clear side-chain densities 
(Supplementary Figure 3) that enabled confident modelling (with sidechains) of 96% of the 
residues (Supplementary Table 1). The global resolution and completeness of the model 
(summarized in Figure 1) now match those of the best resolved thermophilic-bacterial complex 
I structure7, which, until now, has been the gold-standard structure. 
 
Local resolution as an indicator of rigidity  
 
Figure 2 shows how the local resolution of the cryoEM map varies in the core and 
supernumerary subunits, and Supplementary Table 2 gives the local resolution estimate for 
each subunit. The central core subunits are highly resolved, but the resolution decreases 
towards the end of each core domain (Figure 2a), for ND5 in the membrane domain, and for 
NDUFV1, NDUFV2 and the large domain of NDUFS1 at the top of the hydrophilic domain 
(see Supplementary Table 1 for alternative subunit nomenclatures). Notably, the relatively low 
resolutions of these subunits coincide with the smaller surface-area contacts they make with 
the rest of the complex (49, 33, 36 and 30%, respectively, vs. 69 ± 6% for the other core 
subunits, Supplementary Table 2). Figure 2 also shows that the supernumerary subunits are 
lower resolution than the core subunits, and they also have lower contact areas (42 ± 12%) than 
the core subunits. Strikingly, the resolution is asymmetric between the two ‘sides’ of the 
complex (Figure 2b), arguing against imperfect particle alignment (which would affect the 
extremities most) as a substantial effect. The origin of the asymmetry is unclear, although the 
better-resolved side contains the ND5 transverse helix and contacts complex III in the 
respirasome12,30. Finally, supernumerary subunits distant from the core stand out in Figure 2b: 
NDUFA2 and NDUFAB1a contact only the large domain of NDUFS1 and NDUFA6, 
respectively (contact areas 25 and 17%), and NDUFC1 is bound peripherally only to 
supernumerary NDUFC2. The concept of low surface area contacts producing decreased 
resolution through increased structural dispersion or flexibility may thus help to explain how 
the resolution varies through the complex, particularly for the supernumerary subunits, which 
rely less on tight and specific interactions with the complex for their structure and function 
than the core subunits. 
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Assignment of the 3.3 Å resolution structure to the active state, and comparison with a 
deactive structure 
 
The 3.3 Å resolution structure of mouse complex I was assigned to the active state as follows. 
First, global RMSD values calculated in Pymol were much lower for the active (class 2) bovine 
model than the deactive (class 1) or broken (class 3) models (1.6, 3.2 and 4.2 Å, respectively). 
Second, the different orientations of the hydrophilic and membrane domains in the active and 
deactive states, captured visually by the different positions of NDUFA5 (hydrophilic domain) 
and NDUFA10 (membrane domain), show clearly that the mouse structure matches the active 
bovine structure (Figure 3a). Third, densities for all the loops that become disordered in the 
deactive state10,21 are clearly visible in the mouse map, and remained so even when its 
resolution was decreased to 4.3 Å, to match the original bovine structures. 
 
To confirm that the active and deactive states observed for bovine complex I apply equally to 
the mouse enzyme, mouse complex I was prepared in the deactivate state21 and its structure 
determined to 3.9 Å resolution (Supplementary Figure 1), following 3D particle classification 
into a major (69%) and a minor (25%) class (Supplementary Figure 2). Comparisons of the 
minor class with the three classes of bovine complex I10 suggested it represents the active state. 
The model for the major class exhibited the lowest global RMSD value with deactive bovine 
complex I (1.6, 2.4 and 2.7 Å for classes 1, 2 and 3, respectively), and Figure 3a reveals a close 
match in the relative positions of NDUFA5 and NDUFA10. Consistent with deactive bovine 
complex I10,21, no clear densities are observed for the ND1 TMH5-6, ND3 TMH1-2 and 
NDUFS2 b1-b2 loops, or several loops in NDUFA9 (Supplementary Table 1), whereas key 
features not resolved in class 310, notably the ND5 transverse helix, are clearly visible. 
Therefore, the structural changes accompanying deactivation are common to the bovine and 
mouse enzymes, providing a robust basis for understanding the active-deactive transition in 
mammalian complex I. 
 
Figure 3a shows that the interface between NDUFA5 and NDUFA10 (the only contact between 
the hydrophilic and membrane domains outside the main interface) changes upon deactivation. 
In the active state the buried interface of 400 Å2 includes three salt-bridges and three hydrogen 
bonds. In contrast, in the deactive state the interface is decreased to 200 Å2 and includes only 
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one salt-bridge and one hydrogen bond. The implication that interactions between NDUFA5 
and NDUFA10 stabilize the active state is supported by coarse-grained simulations that 
illustrated how NDUFA5 and NDUFA10 restrict global vibrational modes in the mammalian 
complex that resemble the changes required to interconvert the active and deactive states31. 
 
In addition to the loops in ND1, ND3, NDUFS2 and NDUFA9 known to become disordered 
upon deactivation10,21, comparison of the higher-resolution active and deactive mouse 
structures reveals subtle differences in ND1, ND6 and NDUFS7. Figure 3b shows the structural 
elements that become disordered or change between the two states, illustrating how the 
perturbation propagates from the ubiquinone-binding site. In ND6 the TMH3-4 loop is altered, 
and in the deactive map TMH4 is poorly resolved. Furthermore, a striking difference between 
the active and deactive states is revealed in ND6-TMH3. In all existing structures6-8,10-14, a p-
bulge (stretch of p-helix) has been modeled in ND6-TMH3, following its identification in 
bacterial complex I6. The p-bulge is present in deactive mouse complex I, but not in the active 
enzyme. Consequently, in the active state TMH3 is extended, and the residues in its C-terminal 
section are rotated around the helical axis (Figure 3c). Although ND6-Tyr59, which may form 
a functionally-important interaction with ND4L-Glu34, is at the start of the p-bulge and little 
affected, two aromatic residues, Phe67 and Tyr69 (Figure 3d), undergo large changes (Figure 
3e). They rotate, respectively, from between ND4L-TMH2, 3 and ND1-TMH5, ND3-TMH2 
in the deactive state to between ND1-TMH4, 5 and ND3-TMH2, ND4L-TMH3 in the active 
state. The rotation locks the enzyme into different conformations, explaining why ND6 moves 
relative to ND1 and ND3 between the active and deactive states10, and confirming the 
importance of the ND6 p-bulge for catalysis. 
 
Phospholipid densities 
 
Densities for twenty phospholipids were identified in the map for active mouse complex I 
(Figure 4a and Supplementary Table 3, see Supplementary Figure 4 for example densities), 
with many of their headgroup phosphates stabilized by arginines, histidines or tyrosines32. In 
four cases, four acyl chains were observed so they were assigned as cardiolipins. All other 
phospholipids were modelled as phosphatidylethanolamines, unless density features indicated 
phosphatidylcholine is more likely (12 and four cases, respectively). Eight phospholipids 
overlap with the 12 phospholipids modeled previously around ovine complex I11, and nine and 
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11 of them with the 11 and 18 phospholipids modeled around complex I in the porcine12 and 
human13 respirasomes, respectively (Supplementary Table 3). Altogether nine cardiolipins 
have been modeled, corresponding to the ~10 cardiolipins that copurify with bovine complex 
I, along with a similar number of interchangeable phosphatidylethanolamines and 
phosphatidylcholines33.  
 
The locations of the phospholipids (Figure 4a and Supplementary Table 3) suggest they 
stabilize intraprotein and subunit interactions. Four stabilize the C-terminus of ND5, one at its 
interface with NDUFA11 and ND2 and two ‘behind’ its transverse helix, and on the heel they 
stabilize hydrophilic-domain amphipathic helices and supernumerary TMHs against ND1 
(Figure 4b). Many phospholipids are packed between the core membrane subunits. Notably, 
the contact areas between ND2, ND4 and ND5 are low (less than 20% of the surface of ND4 
is buried at interfaces with ND2 and ND5) so, along with the ‘cage’ of supernumerary subunits, 
phospholipids may be crucial for the integrity of the membrane domain. Finally, two 
phospholipids (Figure 4c) interact with NDUFA9 residues relevant to the active-deactive 
transition. In particular, one of them extends from close to the NAD(P)H ribose-phosphate, 
along an interface between NDUFS7 and two regions (a loop in NDUFA9 and the start of the 
ND3-TMH1-2 loop) that become disordered in the deactive state. Therefore, protein-
phospholipid interactions may stabilize loops that are inherently unstable and susceptible to 
becoming disordered. 
 
Nucleotide binding to NDUFA10 
 
The improved resolution of the active mouse structure has allowed the tetrahedral coordination 
of the Zn in NDUFS6 and the acyl chains in NDUFAB1a and NDUFAB1b to be clearly 
visualized, revealed the coordination of the NAD(P)H in NDUFA9 by conserved charged 
residues, confirmed 11 disulfide bonds on the intermembrane space side of the complex — and 
showed that no disulfide is present in the thioredoxin-like subunit NDUFA2 (located in the 
reducing matrix environment). Most strikingly, however, there is clear density for a bound 
nucleotide in subunit NDUFA10, a member of the nucleoside-kinase family (Figures 5a and 
5b) that transfer a phosphate from a nucleotide triphosphate to a nucleoside34. The density has 
been tentatively modeled as ADP, because it resembles a purine nucleoside plus two 
phosphates, and ADP is abundant in the matrix. The putative ADP is coordinated by the 
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sidechains of widely conserved residues: the adenosine by Tyr83, Gln97, Arg104 (which 
interacts with Glu53 and Arg126), Phe134, Glu191 and Tyr198, and the phosphates by Lys35 
(P-loop), Glu125 and Lys186. However, comparison with structural information from 
canonical nucleoside kinases, such as ADP-bound human deoxycytidine kinase35, showed that 
the ADP is bound with its adenosine in the nucleoside-binding site and its two phosphates 
towards the P-loop nucleotide-phosphates binding site (Figure 5d). Therefore, it is bound in a 
configuration resembling the feedback-inhibition mode characterized for deoxythymidine 
triphosphate bound to Drosophila melanogaster deoxyribonucleoside kinase36. 
 
Similar, less well-defined densities are present (but were not interpreted) in NDUFA10 in the 
maps for the human13 and porcine12 respirasomes, but not in the maps for ovine11 or bovine 
complex I10. In the bovine maps increased density in the ADP phosphate-binding region can 
be attributed to phosphorylation of Ser3637 (Figure 5c), which has now been confirmed in the 
structurally-characterized (bovine) preparation (Supplementary Figure 5). Ser36 is conserved 
in ovine complex I, but substituted by Asn or Gly in the mouse, porcine and human homologs, 
suggesting phosphorylation blocks nucleotide binding. Other nucleoside kinases are present in 
mitochondria34, and as the NDUFA10 active site is accessible to solution and key residues are 
present38, phosphorylation of Ser36 and inhibitory substrate binding may together explain why 
no nucleoside kinase activity has yet been reported for mammalian complex I. 
 
The second coordination sphere of cluster N2 
 
The residues surrounding cluster N2, the final cluster in the FeS chain that donates electrons to 
ubiquinone (Figure 1), are clearly resolved in the active mouse complex I map (see, for 
example, Arg85 in Supplementary Figure 3), defining its environment in the mammalian 
enzyme (Figure 6a). Three basic residues, Arg85, Arg105 and His190 in NDUFS2, are close 
to N2 and their positive charges may explain its high reduction potential39. Arg85 is widely 
conserved, but absent from Thermus thermophilus, in which N2 has a lower reduction 
potential39. Furthermore, it has been shown to be symmetrically dimethylated in the 
mammalian and yeast enzymes40, but not in Escherichia coli, in which the N2 reduction 
potential is also unusually low39. Protonation of His190 upon N2 reduction explains why N2 
has a weakly pH-dependent reduction potential41,42. Although the His190Met variant of 
Yarrowia lipolytica complex I remains catalytically competent41,42, molecular simulations have 
suggested His190 deprotonation is required for electron transfer from N2 to semiquinone, and 
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that both His190 and Arg105 (which form a cation π-stacking arrangement) contribute to the 
pH dependence43. Notably, no channels from the His190 sidechain to the outside could be 
detected in Caver analyses (even with a 0.9 Å probe radius). Conversely, similar analyses 
revealed channels from both NDUFS2-Asp104 (within hydrogen-bonding distance of His190) 
and Glu115 (hydrogen bonded to Asp104). Unusually for cryoEM-density maps Asp104 and 
Glu115 both have well resolved sidechains, so their negative charges may be neutralized by 
protonation44. Therefore, they may act as a proton reservoir, for rapid proton delivery to His190 
upon N2 reduction and/or rapid proton capture upon N2 oxidation. 
 
The ubiquinone binding site and E-channel 
 
Tyr108 and His59 in NDUFS2 are generally considered to bind the ubiquinone headgroup in 
complex I by forming hydrogen bonds to its redox-active C=O groups. Both residues are well 
resolved in the mouse map, but positioned too close for ubiquinone to fit between them (5.9 Å 
O-to-N distance). Figure 6b compares the structure with a modeled structure for ubiquinone 
bound to bovine complex I (7.8 Å O-to-N distance)45, showing the substantial change in the 
His59 loop required for binding. Compared to previous structures, the mouse and porcine 
ubiquinone-binding sites match closely12, but differ from the ovine11 and Y. lipolytica14 
structures, which have markedly different His59-loop conformations. The variation attests to 
the flexibility of the site, suggesting it is configured by substrate or inhibitor binding. Finally, 
in the mouse structure the His59 to NDUFS2-Asp160 (O-to-N) distance is 5.0 Å, whereas in 
the modeled ubiquinone-bound bovine45 and T. thermophilus7 structures the two are within 
hydrogen-bonding distance. Although Asp160 has been proposed to undergo large movements 
upon ubiquinone reduction to initiate proton translocation18, its position on a nearby helix is 
conserved in all structures reported so far. 
 
Figure 6c shows how networks of charged residues surround the central section (isoprenoids 
~4-7) of the predicted ubiquinone-binding channel, with the regions before and after dominated 
by hydrophobic residues45. As expected for cryoEM maps, the Arg sidechains in Figure 6c are 
better defined than the (negatively-charged) carboxylates44. Nevertheless, tight interactions are 
observed within the networks (Figure 6c, inset) that, by neutralizing individual charges and 
restricting hydration, may assist the hydrophobic isoprenoids to bind. The charged networks 
may also be involved in coupling ubiquinone reduction to proton translocation. Carboxylate 
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residues on the ND1-TMH5-6 loop (that becomes disordered in the deactive state, but exhibits 
similar conformations in the active mouse and bovine10, porcine12, human13 and T. 
thermophilus7 structures) contribute to the ‘E-channel’7 (Figure 6c), which connects them (and 
thus the ubiquinone-binding site) to the p-bulge in ND6-TMH3 and two glutamates in ND4L, 
presenting a route for energy transfer to the chain of charged residues through ND2, ND4 and 
ND5. 
 
p-helices in ND2, ND4 and ND5  
 
The antiporter-like subunits ND2, ND4 and ND5 contain a common core structure of ten 
TMHs, TMHs 4–13 in ND4 and ND5. In higher metazoans three TMHs have been lost from 
the N-terminus of ND2 during evolution46, so ND2 TMHs 1–10 correspond to ND4 and ND5 
TMHs 4–13. For simplicity, we use the numbering system for ND4 and ND5 throughout. 
TMHs 4–8 and 9–13 comprise two symmetry-related domains6 that face opposite sides of the 
membrane in a front-to-back arrangement related by rotation in an axis along the membrane 
domain. As first observed in E. coli complex I6, symmetry-related TMHs 7 and 12 are 
discontinuous (interrupted in the center by substantial loops), and TMH 8 (but not the 
symmetry-related TMH13) is distorted. The six domains of ND2, ND4 and ND5 thus form 
alternating ‘layers’ of interrupted or distorted (7-8 and 12) and continuous-a-helical (4-6 and 
9-11) TMHs, along the membrane domain (Figure 7a). 
 
The distortions in TMH8 of ND2, ND4 and ND5 have been described as p-bulges, although 
the formal (i + 5 ® i) hydrogen-bonding pattern is not always fulfilled in current structures, 
and they are clearly distorted outside the p-bulges also (Figure 7b and Supplementary Figure 
6). Formal p-bulges are present in ND2-TMH8 only in the T. thermophilus7 and human 
respirasome13 structures, although the mouse and human structures match closely. The p-bulge 
is centered on Leu131, close to Lys135, a conserved charged residue in the central membrane 
plane (Figures 7c and 8a). Comparison of all available structures, particularly the higher-
resolution (£3.3 Å) structures from mouse, T. thermophilus7 and E. coli6, revealed no 
substantial differences in ND2-TMH8 or Lys135. In contrast, in ND4-TMH8, formal p-bulges 
are present in a common position in the E. coli6, human13 and ovine11 structures (the human 
and mouse structures again match closely) but in a different position in T. thermophilus 
complex I7 (Figure 7b). Strikingly, the two p-bulges border a central unwound region that 
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contains conserved Lys237 in different positions, rotated around the helical axis. In ND5-
TMH8, formal p-bulges were detected centered on His248, a further conserved residue, in the 
mouse, porcine12, E. coli6 and T. thermophilus7 structures (Figure 7b). The position of His248 
varies, although the positions of Pro242 and Phe258 are conserved to each side.  
 
Figure 7c compares the positions of the conserved charged residues in ND2, ND4 and ND5, 
and Figure 7e shows how they form a chain along the membrane domain. In each subunit a His 
residue on the loop in interrupted-TMH7 points outside the subunit (Figure 7e, grey labels) 
[ND4-His213 interacts with ND5-Asp554 on the transverse helix, clasping it against ND4]. 
Glutamate residues on TMH5 may be stabilized electrostatically by charged residues on 
interrupted-TMH7 and -TMH12 (Figure 7e, red labels). ND2-Lys135 and ND4-Lys237 
(Figure 7e, blue labels) are on TMH8 but not conserved in ND5. Instead, ND5-His248 on 
TMH8 is positioned, like ND4-His220, closer to the matrix side of the membrane, suggesting 
a role in proton uptake. Further residues, not conserved in all three subunits, contribute 
additional stepping stones along the domain (Figure 7e, black labels).  
 
Finally, the ND5 transverse helix, which runs alongside ND5, ND4 and ND2 (Figure 1), was 
originally proposed to consistute an important coupling element for energy transfer6 — 
although this proposal was subsequently challenged by alterations to the helix that do not 
substantially affect catalysis47,48. The transverse helix contains a substantial stretch of p-helix 
in the mouse structure (Figure 7d), and also in the porcine and E. coli structures (in which the 
C-terminus of ND5 is clearly resolved)6,12. Conversely, in T. thermophilus complex I7 the 
transverse helix is a-helical throughout, except for a short distortion at the start. Despite these 
differences in structure, the position of ND5-Asp554, which interacts with ND4-His213 and 
has been proposed to be important for catalysis49, is conserved, and the whole transverse helix 
extends the same distance in each case — due to its different structures it contains three more 
residues in mouse than in T. thermophilus, and five more than in E. coli. 
 
Discussion 
 
A central question for complex I research is the mechanism of energy transduction: how energy 
from the redox reaction is captured, transferred through the protein, and consumed in proton 
transport. Here, we have provided the first experimental evidence for conformational changes 
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in helical structures in the membrane domain. First, we reveal that ND6-TMH3 contains a p-
bulge in the deactive state, but not the active state. Thus, it may be held in an energized 
conformation for catalysis, or the p-bulge may be formed and destroyed during each cycle to 
induce conformational changes. Second, we reveal differences in TMH8 in ND2, ND4 and 
ND5, resulting from different helical geometries and p-bulges in different subunits and species, 
which may simply reflect how they have come to rest following catalysis. Crucially, ND4-
Lys237, a conserved charged residue, takes up different rotational positions around the helical 
axis, such that when the mouse residue is placed into the position observed in T. thermophilus 
the Lys-Nz comes into hydrogen-bonding distance of ND4-His220 (Figure 7e). We therefore 
propose that geometrical changes in TMH8 may form and destroy interactions within the chain 
of charged residues, suggesting a mechanism for energy propagation. Specific water molecules 
have also been proposed, on the basis of computational simulations, to be crucial for forming 
functional connections within the chain17,19,20. Similar rotations of residues around a helical 
axis due to p-helix geometry changes have been observed previously in methane 
monooxygenase hydroxylase upon substrate binding15,50. Interestingly, comparable changes 
are not observed in TMH13, the symmetry-related partner of TMH8. TMH8 contributes to the 
matrix half-channel7, so we may speculate that the energy required for proton translocation is 
consumed mostly in proton uptake (rather than expulsion). Finally, the transverse helix in the 
mammalian enzyme also contains p-helical structure, which, if it is catalytically-relevant, could 
move along the helix during catalysis but not be formed or destroyed, because the helix ends 
are anchored. Alternatively, the compressed p-helix geometry may contribute to the 
pronounced curvature of the mammalian membrane domain and, consistent with increased 
resolution on this side of the structure (Figure 2b), ‘pull’ the otherwise-loosely-associated ND2, 
ND4 and ND5 subunits together into a tightly-bound functional assembly. 
 
Originally, the driving force for cryoEM studies on mouse complex I was to enable molecular-
level characterization of complex I-linked mitochondrial disease models. For example, the 
physiological effects of deleting subunit NDUFS4 have been studied extensively in mice51, but 
a molecular description of the compromised assembly, stability or reactivity of the complex 
remains obscure. However, despite technical challenges from the small scale of the preparation, 
the mouse enzyme led to a much higher resolution map, from far fewer particles, than the large-
scale bovine preparation characterized previously. Although changes have been made to our 
data collection strategies (use of a K2 instead of a Falcon II detector, at higher magnification, 
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and use of PEGylated-gold instead of carbon-Quantfoil grids21), and we have used updated 
data analysis software52,53, the fact that the mouse particles gave a single major class of the 
active state, rather than a mixture of active, deactive and broken states, is likely crucial for the 
improvement. We propose the increased homogeneity results from the much shorter time 
required to extract and cool the mouse-heart tissue. During slaughterhouse procedures and 
transport to the laboratory the large bovine heart maintains its temperature and becomes 
ischemic, promoting both degradation and deactivation. In any case, the resolution available 
from cryoEM studies of mammalian complex I is now sufficient to visualize individual 
sidechains and access mechanistically-relevant information. Structures of the enzyme trapped 
in different intermediate states are required next, for further elucidation of its mechanism of 
catalysis. 
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Figures 
 
 
 
Figure 1.  Overview of the structure of mouse complex I. The fourteen core subunits are in 
color and labelled accordingly and the 26 supernumerary subunits are in white. The positions 
of the flavin mononucleotide (FMN), at the NADH binding site, and FeS cluster N2, the 
immediate electron donor to ubiquinone, are indicated. The structure of the cofactor chain, 
together with the modeled structure of ubiquinone-1045, is shown separately in the inset also.  
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Figure 2.  The resolution of densities for the core and supernumerary subunits in the 3.3 
Å resolution map of active mouse complex I. Local resolutions were estimated using the 
Local Resolution function in RELION with default parameters. The figure was created using 
UCSF Chimera, using the model to separate the core (a) and supernumerary (b) subunit 
densities. 
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Figure 3.  Differences in structure 
between the active and deactive 
states of mouse complex I. a) Left - 
NDUFA5, on the hydrophilic domain, 
and NDUFA10, on the membrane 
domain, form a second contact 
between the two domains. Right – the 
different arrangements of NDUFA5 
and NDUFA10 are illustrated by 
superimposing the NDUFA10 subunit 
in the NDUFA5-NDUFA10 pairs 
from the bovine and mouse deactive 
and active states. NDUFA5 is present 
in markedly different positions in the 
active (red) and deactive (wheat and 
grey) states. b) Structural elements 
that become disordered or change 
between the active and deactive states. 
The ubiquinone binding channel determined by CAVER 3.054 is shown for reference. c) The 
different structures of ND6-TMH3 in the active (red) and deactive (wheat) states, 
superimposed on the N-terminal section, and the positions of key sidechains. The p-bulge is 
present only in the deactive state. d) Densities for key sidechains in the active state. e) 
Rotation of the bulky sidechains of Phe67 and Tyr69 between the TMHs of ND3, ND4L and 
ND1. The structures were superimposed on ND4L with the active structure colored by 
subunit and the deactive in wheat. Only the TMHs are shown, plus the loops between ND3-
TMHs 1 and 2 and ND6-TMHs 3 and 4. 
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Figure 4.  Phospholipids in the 3.3 Å resolution structure of mouse complex I. a) 
Membrane-bound helices in the complex I viewed from the matrix side, with phospholipids 
in red and labelled with the nomenclature in Supplementary Table 3. b) Phospholipids 
stabilizing amphipathic helices on the matrix side of the heel of the complex. The structure 
shown in blue is from supernumerary subunits NDUFA1, NDUFA3, NDUFA7, NDUFA12 
and NDUFA13 and phosphorus atoms are marked with spheres. c) Two phospholipids that 
interact with NDUFA9 may stabilize loops in ND3 and NDUFA9 that become disordered in 
the deactive state (shown in darker colors than the rest of the two subunits). The arrows on 
the insets to b) and c) indicate the directions of view. 
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Figure 5.  Nucleotide/nucleoside binding to NDUFA10. a) Density for the bound 
nucleotide/nucleoside (modeled as ADP) in NDUFA10 in active mouse complex I. The 
density has been carved around the modeled ADP and the phosphate in the overlaid model 
from panel c (2 Å carve radius, threshold level of 0.075). Key residues that interact with the 
nucleotide/nucleoside are indicated, and Asn36, the homolog of Ser36 is in green. b) 
Overview of the typical nucleoside-kinase fold of NDUFA10 with nucleotide bound and the 
P-loop adjacent to the bound phosphates. c) The nucleotide/nucleoside-binding site in bovine 
complex (taken from PDB 5O3121) with a phosphate added to the side-chain of Ser36 (green) 
on the basis of mass spectrometry evidence. The density has been carved around the 
phosphate and the ADP in the overlaid model from panel a (2 Å carve radius, threshold level 
of 0.16). d) Comparison of the binding mode of the ADP modeled in NDUFA10 (red) with 
deoxythymidine triphosphate bound in the feedback inhibition mode in Drosophila 
melanogaster deoxyribonucleoside kinase (PDB 1OE036, blue) and with ADP (green) and a 
nucleoside analog (wheat) in the substrate-binding site of human deoxycytidine kinase (PDB 
2ZI435). The structures were overlaid using the whole nucleoside kinase fold structures.  
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Figure 6.  The environment of cluster N2, the ubiquinone-binding channel and the E-
channel in active mouse complex I. a) Cluster N2 and nearby key residues in NDUFS2. 
Dimethyl-Arg85 and Arg105 are positively charged, His190 is the redox-Bohr group that 
changes protonation state upon N2 reduction41,42, and Asp104 and Glu115 may transfer 
protons to/from His190. b) The structure around the ubiquinone-headgroup binding site with 
key residues in NDUFS2. The structure of active mouse complex I (wheat) is overlaid on the 
modeled structure of bovine complex I with ubiquinone-10 bound (teal)45 in which hydrogen 
bonds are present between the headgroup and Tyr108 and His59, and His59 and Asp160. 
Distances in brackets are for the active mouse structure. c) The ubiquinone-binding channel 
(mesh) in active mouse complex I was predicted using CAVER 3.054 with a 1.4 Å probe 
radius. The key residues from panel b are shown with charged residues in the vicinity of the 
site (inset, charged residues around the center of the channel and their interactions). The main 
figure highlights the carboxylate-rich ND1 TMH 5-6 loop and the E channel residues (blue) 
that connect the ubiquinone-binding site to the p-helix present in ND6 in the deactive 
enzyme, and to charged residues in the central membrane plane7. Long distances of interest 
are in red, and all residues are in ND1 unless otherwise indicated (B - NDUFS7, D - 
NDUFS2, J - ND6 and K - ND4L). All distances are in Å. 
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Figure 7.  Charged residues and discontinuous and p-helices in subunits ND2, ND4 and 
ND5. a) Overview of subunits ND2, ND4 and ND5 showing the layered arrangement of core 
TMHs 4 to 13.  TMHs 4 to 6 (red) and 9 to 11 (magenta) are a helical whereas TMH7 is 
discontinuous, TMH8 contains p-helical structure (cyan) and TMH12 (blue) is also 
discontinuous. The transverse helix from ND5 is also shown. b) TMH8 in ND2, ND4 and 
ND5 orientated with the mitochondrial matrix at the top. c) Overlay of conserved charged 
residues in the central membrane plane in ND2, ND4 and ND5. A cartoon representation of 
ND4 is shown for reference, and conserved residues1,7 are colored cyan for ND2, green for 
ND4 and pink for ND5. Numbers refer to ND4, except for residues only in ND5 numbered in 
grey. d) Comparison of structures of the transverse helix in ND5 with TMH16 (the C-
terminus) on the right and the conserved aspartate residue indicated. Groups of structures 
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have been aligned using the whole subunit structures. The ribbons join the Ca atoms 
together, and each fifth residue is numbered. The approximate positions of stretches of p-
helix are indicated. e) The distribution of charged residues and helical elements along the 
membrane arm with key residues labelled and the distances between ionizable groups shown 
in Å. TMH7 and 12 are in red and TMH8 is in blue. Residues labeled in red are on TMH5, 
TMH7 and TMH12. The mouse structure is for the active state, the structure of T. 
thermophilus complex I is from PDB 4HEA7 and the structure of the membrane domain of 
complex I from E. coli is from PDB 3RKO6. 
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Table 1.  Cryo-EM data collection, refinement and validation statistics. 
 
 Active state 
(EMDB 4345, PDB 
6G2J) 
Deactive state 
(EMDB 4356, PDB 
6G72) 
Data collection and processing   
Magnification    47,600 37,600 
Voltage (kV) 300 300 
Electron exposure (e–/Å2) 50 50 
Defocus range (µm) -1.5 to -3.1 -2.2 to -3.4 
Pixel size (Å) 1.05 1.33 
Symmetry imposed None None 
Initial particle images (no.) 60,851 40,131 
Final particle images (no.) 20,370 17,066 
Map resolution (Å) 
    FSC threshold 
3.3 
0.143 
3.9 
0.143 
Map resolution range (Å) 472 to 3.3 484 to 3.9 
   
Refinement   
Initial model used  PDB 5LC5 PDB 6G2J 
Model resolution (Å) 
    FSC threshold 
3.6 
0.5 
4.1 
0.5 
Model resolution range (Å) 472 to 3.3 484 to 3.9 
Map sharpening B factor (Å2) -61 -67 
Model composition 
    Nonhydrogen atoms 
    Protein residues 
    Ligands 
 
66,811 
8,164 
34 
 
64,923 
8,072 
14 
B factors (Å2) 
    Protein 
    Ligand 
 
47 
45 
 
71 
67 
R.m.s. deviations 
    Bond lengths (Å) 
    Bond angles (°) 
 
0.009 
1.33 
 
0.012 
1.33 
 Validation 
    MolProbity score 
    Clashscore 
    Poor rotamers (%)    
 
2.03 
6.63 
0.06 
 
2.18 
9.10 
0.23 
Ramachandran plot 
    Favored (%) 
    Allowed (%) 
    Disallowed (%) 
 
84.7 
14.9 
0.4 
 
82.7 
16.9 
0.4 
 
  
 27 
Online Methods 
 
Preparation of mouse complex I  
 
C57BL/6 mice were sacrificed by cervical dislocation in accord with the UK Animals 
(Scientific Procedures) Act, 1986 (PPL: 70/7538, approved by the local ethics committee and 
the UK Home Office). Hearts (typically 0.17 g) were excised, then immersed immediately in 
cold solution containing 10 mM Tris-HCl (pH 7.4 at 4 °C), 75 mM sucrose, 225 mM sorbitol, 
1 mM EGTA, and 0.1% (w/v) fatty acid-free bovine serum albumin (Sigma-Aldrich). By 
coordinating with other researchers, most of the hearts used were harvested from animals also 
required for other purposes. All the following procedures were at 4 °C. Mitochondria were 
isolated from heart tissue as described previously55. Briefly, the hearts were cut into 1 mm 
sized pieces, washed, then homogenized (10 mL buffer (g tissue)-1) by 7-10 strokes of a Potter-
Elvehjem homogenizer fitted with a Teflon pestle at ~1000 rpm. The homogenate was 
centrifuged (1,000 x g, 5 min.), then the supernatant centrifuged (9,000 x g, 10 min.) to collect 
the crude mitochondria. They were washed several times by resuspension and centrifugation 
then collected by centrifugation at 15,000 x g for 2 min., resuspended in 20 mM Tris-HCl (pH 
7.4 at 4 °C), 1 mM EDTA and 10% (v/v) glycerol to 10-20 mg protein mL-1 and frozen for 
storage. The total time required from extracting the first heart to freezing the mitochondria was 
less than two hours. Mitochondria were thawed, diluted to 5 mg protein mL-1, then ruptured by 
three 5 s bursts of sonication (with 30 s intervals on ice) using a Q700 Sonicator (Qsonica) at 
65% amplitude setting. The membranes were collected by centrifugation (75,000 x g, 1 hour), 
resuspended to 5 mg protein mL-1 and frozen for storage. The active enzyme preparation used 
27.3 mg of membrane protein, isolated from 26 hearts that had been harvested from two batches 
of 10 and 16 mice. The deactive enzyme preparation used 17.2 mg of membrane protein, 
isolated from a single batch of 20 hearts. 
 
Complex I was prepared using a method adapted from that for bovine complex I33. 
Mitochondrial membranes, typically containing ~15 mg protein, were thawed, then 1% n-
dodecyl β-D-maltoside (DDM, Glycon) and 0.005% (w/v) PMSF were added, the mixture 
stirred for 30 min. to solubilize the complexes and centrifuged (48,000 x g, 30 min.). The 
supernatant was loaded onto a 1 mL Hi-Trap Q HP anion exchange column (GE Healthcare) 
pre-equilibrated with buffer A (20 mM Tris-HCl (pH 7.14 at 20 °C), 1 mM EDTA, 0.1% DDM, 
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10% (v/v) ethylene glycol, 0.005% asolectin (Avanti) and 0.005% CHAPS (Calbiochem)). The 
column was washed at 0.3 mL min-1 with buffer A for 2 min. then with 20% buffer B (buffer 
A + 1 M NaCl) for 7 min., then complex I was eluted in 35% buffer B for 10 min. Complex I-
containing fractions (typically 1 mL total) were pooled and concentrated to ~100 µL using a 
100 kDa cut-off Vivaspin 500 concentrator (Sartorius), loaded onto a Superose 6TM Increase 
5/150 column (GE Healthcare) and eluted in 20 mM Tris-HCl (pH 7.14 at 20 °C), 150 mM 
NaCl and 0.05% DDM at 0.03 mL min-1. Complex I eluted at ~1.65 mL, and the highest 
concentration fraction (3 – 5 mg mL-1) was collected and used directly for cryoEM grid 
preparation. Typically, the NADH:decylubiquinone oxidoreductase activity was 10-12 µmol 
min-1 mg-1. For the deactive enzyme the membranes were incubated at 37 ºC for 30 min. with 
the ratio of active and deactive complexes monitored by comparing the rates of NADH 
oxidation following a 5 min treatment with or without 2.5 mM N-ethyl maleimide, as described 
previously21. The proportion of active complex I decreased from 94 ± 13 to 39 ± 7% during the 
incubation. 
 
Electrospray ionization-MS was performed on purified bovine complex I as described 
previously56 on a Sciex 4000QTRAP spectrometer, and data analyzed using Peakview 2.1. 
Tryptic digests of the NDUFA10-containing region were extracted from SDS-PAGE gels of 
the iodoacetamide-treated enzyme and analyzed by LTQ Orbitrap XL as described 
previously57, except using the ETD fragmentation mode. 
 
CryoEM grid preparation and imaging 
 
UltrAuFoil® gold grids (0.6/1, Quantifoil Micro Tools GmbH)28 were prepared as described 
previously21. Briefly, they were glow discharged (20 mA, 60 s), incubated in a solution of 5 
mM 11-mercaptoundecyl hexaethyleneglycol (SPT-0011P6, SensoPath Technologies) in 
ethanol29 for two days in an anaerobic glovebox, then washed with ethanol and air-dried just 
before use. Using an FEI Vitrobot Mark IV, 2.5 µL of complex I solution (3 – 5 mg mL-1) were 
applied to each grid at 4 °C in 100% relative humidity, and blotted for 8 – 16 s at force setting 
-10, before the grid was frozen by plunging it into liquid ethane. 
 
Grids were imaged using a Gatan K2 summit camera and GIF Quantum energy filter mounted 
on an FEI 300 keV Titan Krios microscope with a 100 µm objective aperture and EPU-1.9 
software. Data for the active complex were recorded at the Astbury Centre for Structural 
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Molecular Biology, University of Leeds, and data for the deactive complex at the UK National 
electron Bio-Imaging Centre (eBIC) at the Diamond Light Source. The detectors were operated 
in counting mode, and the energy filters in zero-energy-loss mode with a slit width of 20 eV. 
The active complex was imaged at 1.05 Å/pixel (47,600× actual magnification) and the 
deactive complex at 1.33 Å/pixel (37,600× actual magnification) with defocus ranges -1.5 to -
3.1 µm and -2.2 to -3.4 µm, respectively, and the autofocus routine run every 10 µm. For the 
active complex, the dose rate was 5 electrons Å-2 s-1 with 10 s exposures captured in 25 frames; 
for the deactive complex it was 3.25 electrons Å-2 s-1 with 15 s exposures captured in 30 frames. 
The total dose was thus ~50 electrons Å-2 in each case. 
 
Data processing 
 
All analyses were carried out using the RELION 2.1 (patch b1) pipeline52,53. First, MotionCor2-
1.0.5 (with dose weighting) was applied to both datasets to account for beam-induced 
movement58 and Gctf-1.06 was used for CTF estimation59. Then, for the active complex, 
60,851 particles were extracted following autopicking and manual curation and subjected to 
2D classification; 28,935 particles were retained. Following an initial movie refinement with a 
three frame running average, the particles were subjected to ‘particle polishing’, using default 
parameters for B-factor weighting; the highest resolution reconstruction was obtained using 
frames 1–12. The particles were then subjected to 3D classification into five classes, with the 
angular sampling increased to 3.7°. The two major classes (containing a total of 20,370 
particles, 70%) were indistinguishable and combined for the final 3D autorefinement. The final 
resolution of the map is 3.3 Å. For the deactive complex, 40,131 particles were picked 
manually. Following one round of 2D classification (leaving 30,378 particles), a preliminary 
3D autorefinement was performed and the particles re-centered and re-extracted. Then 24,644 
particles were retained from 3D classification with a coarse angular sampling of 7.5°. 
Following an initial movie refinement with a five frame running average, particle polishing 
was performed  using the default parameters for B-factor weighting; the highest resolution 
reconstruction was obtained using all 30 frames. The polished particles were then subjected to 
high-resolution 3D classification. The resolution was limited to 8 Å, 5 classes were provided 
and the angular sampling was increased gradually from 7.5° to 0.9°. Two major classes were 
obtained. The highest resolution class, which was attributed to the deactive enzyme, contained 
69% (17,066) of the particles and was taken forward to 3D autorefinement, leading to a 3.9 Å 
resolution map. The second class, containing 25% of the particles, matched the structure of the 
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active enzyme and the remaining three classes contained negligible numbers of particles. In all 
cases, the final 3D autorefinements used solvent-flattened FSC curves with a soft mask to 
minimize the effects of the large solvent contribution; this increases the accuracy of the 
resolution estimate after each iteration and gave slight increases in resolution. Finally, post-
processing was performed with default parameters using masks created from fitted coordinate 
files (using the Molmap command in UCSF Chimera (1.11.2)60 and mask creation tools in 
RELION) in order to exclude interference from the detergent belt. Resolution estimates were 
based on the gold standard FSC = 0.143 criterion61. 
 
Global structure resolutions were estimated from FSC curves in RELION61, as shown in 
Supplementary Figure 1. Local resolutions were estimated using the Local Resolution function 
in RELION (similar to the ‘blocres’ function in Bsoft62), with default parameters (sphere of 
radius 12.5 Å with a soft edge of 25 Å). Using the local resolution function to estimate the 
overall resolution of the active state structure gave 3.4 Å, close to the globally-calculated value 
of 3.3 Å. For individual subunits, UCSF Chimera was used to extract the resolution at each 
atomic coordinate and the values were averaged. Values calculated by masking individual 
subunit volumes in the local resolution map gave equivalent results. 
 
Model building 
 
The model for the active complex (Supplementary Table 1) was built first using Coot 
(0.8.9.1)63 and existing models for bovine complex I (PDB 5LC510 and PDB 5O3121) as 
templates, with the residues converted to the mouse sequences. The core subunit models were 
easily fit into the density map, with good agreement between the map and initial models; the 
only significant extension was to the C-terminus of NDUFV2. In total 4,408 core residues were 
modeled out of 4,504 (97.9%). The supernumerary subunits were less well resolved in the 
bovine maps, so the template models were less accurate. However, the higher resolution of the 
current map revealed clear side-chain densities for the majority of residues, allowing all 31 
supernumerary subunits to be confidently modeled. The structure on the intermembrane-space 
side of the tip of the membrane domain is relatively poorly resolved; although we were able to 
extend NDUFB2 (C-terminus), NDUFB6 (C-terminus), NDUFB7 (N-terminus) and NDUFB8 
(C-terminus) around the already-built C-terminal helix of NDUFB7, the model is less confident 
in this region. A number of minor extensions were added to other supernumerary subunits. In 
total 3,756 supernumerary residues were modeled out of 4,014 (93.6%). Thus, overall 95.9% 
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of the residues were modeled, 95.7% with sidechains. Stretches of more than 10 unresolved 
residues comprise the likely flexible amino and carboxy termini of NDUFS1, NDUFS3, 
NDUFS7 (34 residues at the N-terminus), NDUFA2, NDUFA6, NDUFB3, NDUFB7, 
NDUFB11 and NDUFV3, as well as 13 residues in the middle of NDUFA7 and 26 residues in 
the middle of NDUFB6 (Supplementary Table 1). 
 
The densities observed for the phosphopantetheine and acyl groups attached to both copies of 
NDUFAB1 were modeled using 11 and 12 carbon chains for chains T and U, respectively, 
matching the lengths of density observed. The unknown nucleotide bound to NDUFA10 was 
modeled as ADP. Arg-85 of NDUFS2 was modeled as symmetrically dimethylated based on 
the results from mass spectrometry analyses40 and the bulky density observed for its headgroup. 
The densities for possible disulfide bonds were inspected individually and bonds formed where 
appropriate: in the four CHCH domains in NDUFA8, NDUFB7 and NDUFS5 and in 
NDUFB10 (Cys76-Cys89 and Cys112-Cys123) which are all on the intermembrane space side, 
and at the membrane-intermembrane space interface in NDUFA11 (Cys20-Cys77). No density 
was observed for the disulfide between Cys94 and Cys114 in NDUFA11 observed previously 
in the porcine respirasome12. Post-translational modifications to peptide termini detected in 
bovine complex I3, notably N-formylation and N-acetylation, were assumed to be identical if 
the residues are conserved in mouse, and built where possible. Densities for twenty 
phospholipid molecules were identified and modeled as cardiolipin (PDB code CDL) in cases 
where four acyl chains were observed, or as phosphatidylethanolamine (3PE), unless density 
features indicated that phosphatidylcholine (PC1) is more likely. 
 
The model was refined into the map by real-space refinement in Phenix 1.1364 using default 
parameters without secondary structure restraints. Cycles of manual adjustment and Phenix 
refinement were used to obtain the final model. The results were assessed by MolProbity 4.465 
(see Table 1) and EMringer66 (score 3.37). 
 
To build the deactive model, the model for the active complex was fitted roughly into the 
deactive map using the ‘fit-in-map’ function in UCSF Chimera, then rigid body refinement in 
Phenix was used to optimize the fit for each chain. Loops in ND1, ND3, NDUFS2 and 
NDUFA9 that are not observed in the bovine deactive structure were not observed in the 
deactive mouse enzyme either so were deleted from the model (Supplementary Table 1) giving 
a total of 94.8% of the residues modeled. Phospholipids were also removed from the deactive 
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model since their densities were not sufficiently clearly defined. The final model was obtained 
by cycles of manual adjustment and Phenix refinement and assessed by MolProbity 4.465 (see 
Table 1) and EMringer66 (score 2.10). 
 
Secondary structures were analyzed using DSSP (http://swift.cmbi.ru.nl/gv/dssp/)67. Surface 
areas of contacts between subunits were calculated using the PDBePISA server 
(http://www.ebi.ac.uk/pdbe/pisa/)68. The ubiquinone-binding channel was predicted using 
CAVER 3.054 with a with a 1.4 Å probe radius, starting from the sidechain O atom of NDUFS2-
Tyr108. Protein structure and density figures were created using MacPymol or UCSF Chimera. 
 
Data Availability Statement 
The electron microscopy maps and masks and the models for the active and deactive states 
have been deposited in the Electron Microscopy Data Bank (EMDB) with accession numbers 
EMD-4345 (active) and EMD-4356 (deactive), and in the Protein Data Bank with accession 
codes 6G2J (active) and 6G72 (deactive). 
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